Waldron Private Wealth LLC Biomarin Pharmaceutical Inc Transaction History

Waldron Private Wealth LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Aug 29, 2024	BUY	$87.74 - $117.27 $535,740 - $716,050	6,106 New	6,106 $593,000
Q1 2023 May 02, 2023	SELL	$87.74 - $117.27 $3,772 - $5,042	-43 Reduced 0.7%	6,106 $593,000
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $3,779 - $4,459	46 Added 0.75%	6,149 $521,000
Q2 2022 Aug 03, 2022	BUY	$71.48 - $86.85 $7,148 - $8,685	100 Added 1.67%	6,103 $505,000
Q1 2022 May 04, 2022	BUY	$74.28 - $92.69 $1,857 - $2,317	25 Added 0.42%	6,003 $462,000
Q4 2021 Feb 02, 2022	BUY	$71.72 - $91.47 $428,742 - $546,807	5,978 New	5,978 $528,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Waldron Private Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Waldron Private Wealth LLC with notifications on news.